{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:01:35Z","timestamp":1780718495632,"version":"3.54.1"},"reference-count":27,"publisher":"Japanese Society of Veterinary Science","issue":"6","funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2018R1D1A1B07042793"],"award-info":[{"award-number":["2018R1D1A1B07042793"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1292\/jvms.26-0071","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T22:14:28Z","timestamp":1776291268000},"page":"893-901","source":"Crossref","is-referenced-by-count":0,"title":["Cisplatin-induced acute kidney injury in lupus-prone NZB\/W F1 mice: a potential experimental model of acute kidney injury superimposed on chronic kidney disease"],"prefix":"10.1292","volume":"88","author":[{"given":"Eun Wha","family":"CHOI","sequence":"first","affiliation":[{"name":"Department of Veterinary Clinical Pathology, College of Veterinary Medicine &amp; Institute of Veterinary Science, Kangwon National University, Chuncheon, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Anders HJ, Saxena R, Zhao MH, Parodis I, Salmon JE, Mohan C.  2020. Lupus nephritis. <i>Nat Rev Dis Primers<\/i> 6: 7.","DOI":"10.1038\/s41572-019-0141-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute Dialysis Quality Initiative workgroup. 2004. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. <i>Crit Care<\/i> 8: R204\u2013R212.","DOI":"10.1186\/cc2872"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. B\u00f6hme R, Daniel C, Ferrazzi F, Angeloni M, Ekici AB, Winkler TH, Hilgers KF, Wellmann U, Voll RE, Amann K.  2023. Cardiovascular changes in the NZB\/W F1 mouse model of lupus nephritis. <i>Front Cardiovasc Med<\/i> 10: 1182193.","DOI":"10.3389\/fcvm.2023.1182193"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Chawla LS, Eggers PW, Star RA, Kimmel PL.  2014. Acute kidney injury and chronic kidney disease as interconnected syndromes. <i>N Engl J Med<\/i> 371: 58\u201366.","DOI":"10.1056\/NEJMra1214243"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Choi EW, Kim HJ, Jung YC, Go HS, Seong JK.  2022. Effects of high fat diet-induced obesity on pathophysiology, immune cells, and therapeutic efficacy in systemic lupus erythematosus. <i>Sci Rep<\/i> 12: 18532.","DOI":"10.1038\/s41598-022-21381-3"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Choi EW, Lee HW, Shin IS, Park JH, Yun TW, Youn HY, Kim SJ.  2016. Comparative efficacies of long-term serial transplantation of syngeneic, allogeneic, xenogeneic, or CTLA4Ig-overproducing xenogeneic adipose tissue-derived mesenchymal stem cells on murine systemic lupus erythematosus. <i>Cell Transplant<\/i> 25: 1193\u20131206.","DOI":"10.3727\/096368915X689442"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Choi EW, Shin IS, Park SY, Park JH, Kim JS, Yoon EJ, Kang SK, Ra JC, Hong SH.  2012. Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation. <i>Arthritis Rheum<\/i> 64: 243\u2013253.","DOI":"10.1002\/art.33313"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Coca SG, Singanamala S, Parikh CR.  2012. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. <i>Kidney Int<\/i> 81: 442\u2013448.","DOI":"10.1038\/ki.2011.379"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Devarajan P.  2010. Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. <i>Biomarkers Med<\/i> 4: 265\u2013280.","DOI":"10.2217\/bmm.10.12"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A.  2004. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. <i>Nature<\/i> 432: 917\u2013921.","DOI":"10.1038\/nature03104"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Girimaji N, Nada R, Sharma A, Bharati J, Rathi M.  2021. Complete remission of lupus nephritis following chemoradiotherapy of carcinoma cervix: An association. <i>Indian J Nephrol<\/i> 31: 402\u2013405.","DOI":"10.4103\/ijn.IJN_267_20"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK.  2002. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. <i>Mol Cell<\/i> 10: 1033\u20131043.","DOI":"10.1016\/S1097-2765(02)00708-6"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Groothof D, Post A, Polinder-Bos HA, Erler NS, Flores-Guerrero JL, Kootstra-Ros JE, Pol RA, de Borst MH, Gansevoort RT, Gans ROB, Kremer D, Kieneker LM, Bano A, Muka T, Franco OH, Bakker SJL.  2022. Muscle mass and estimates of renal function: a longitudinal cohort study. <i>J Cachexia Sarcopenia Muscle<\/i> 13: 2031\u20132043.","DOI":"10.1002\/jcsm.12969"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A. NGAL Meta-analysis Investigator Group. 2009. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. <i>Am J Kidney Dis<\/i> 54: 1012\u20131024.","DOI":"10.1053\/j.ajkd.2009.07.020"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Khwaja A.  2012. KDIGO clinical practice guidelines for acute kidney injury. <i>Nephron Clin Pract<\/i> 120: c179\u2013c184.","DOI":"10.1159\/000339789"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute Kidney Injury Network. 2007. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. <i>Crit Care<\/i> 11: R31.","DOI":"10.1186\/cc5713"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P.  2005. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. <i>Lancet<\/i> 365: 1231\u20131238.","DOI":"10.1016\/S0140-6736(05)74811-X"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P.  2003. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. <i>J Am Soc Nephrol<\/i> 14: 2534\u20132543.","DOI":"10.1097\/01.ASN.0000088027.54400.C6"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ozkok A, Edelstein CL.  2014. Pathophysiology of cisplatin-induced acute kidney injury. <i>BioMed Res Int<\/i> 2014: 967826.","DOI":"10.1155\/2014\/967826"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Pabla N, Dong Z.  2008. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. <i>Kidney Int<\/i> 73: 994\u20131007.","DOI":"10.1038\/sj.ki.5002786"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Parikh CR, Coca SG, Thiessen-Philbrook H, Shlipak MG, Koyner JL, Wang Z, Edelstein CL, Devarajan P, Patel UD, Zappitelli M, Krawczeski CD, Passik CS, Swaminathan M, Garg AX. TRIBE-AKI Consortium. 2011. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. <i>J Am Soc Nephrol<\/i> 22: 1748\u20131757.","DOI":"10.1681\/ASN.2010121302"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Peres LAB, da Cunha AD Jr 2013. Acute nephrotoxicity of cisplatin: molecular mechanisms. <i>J Bras Nefrol<\/i> 35: 332\u2013340.","DOI":"10.5935\/0101-2800.20130052"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Rahman A, Isenberg DA.  2008. Systemic lupus erythematosus. <i>N Engl J Med<\/i> 358: 929\u2013939.","DOI":"10.1056\/NEJMra071297"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ravichandran K, Wang Q, Ozkok A, Jani A, Li H, He Z, Ljubanovic D, Weiser-Evans MC, Nemenoff RA, Edelstein CL.  2016. CD4 T cell knockout does not protect against kidney injury and worsens cancer. <i>J Mol Med (Berl)<\/i> 94: 443\u2013455.","DOI":"10.1007\/s00109-015-1366-z"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Wang S, Wang F, Wang X, Zhang Y, Song L.  2021. Elevated creatinine clearance in lupus nephritis patients with normal creatinine. <i>Int J Med Sci<\/i> 18: 1449\u20131455.","DOI":"10.7150\/ijms.51117"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Wang Y, Hu Q, Madri JA, Rollins SA, Chodera A, Matis LA.  1996. Amelioration of lupus-like autoimmune disease in NZB\/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. <i>Proc Natl Acad Sci USA<\/i> 93: 8563\u20138568.","DOI":"10.1073\/pnas.93.16.8563"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Zhao J, Wang H, Huang Y, Zhang H, Wang S, Gaskin F, Yang N, Fu SM.  2015. Lupus nephritis: glycogen synthase kinase 3\u03b2 promotion of renal damage through activation of the NLRP3 inflammasome in lupus-prone mice. <i>Arthritis Rheumatol<\/i> 67: 1036\u20131044.","DOI":"10.1002\/art.38993"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/88\/6\/88_26-0071\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:22:23Z","timestamp":1780716143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/88\/6\/88_26-0071\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.26-0071","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"26-0071"}}